The Oncology Institute, Inc. (TOI)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Patient Services	213.50M
Patient Services Growth	28.01%
Dispensary	103.84M
Dispensary Growth	30.87%
Clinical Trials & Other	6.90M
Clinical Trials & Other Growth	8.58%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
United States	324.24M
United States Growth	28.42%